Phase I single-dose trial of ICA 105665 in male volunteers.

Trial Profile

Phase I single-dose trial of ICA 105665 in male volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 25 Nov 2009

At a glance

  • Drugs ICA 105665 (Primary)
  • Indications Epilepsy
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Neusentis
  • Most Recent Events

    • 25 Nov 2009 Results will be presented at the 63rd Annual Meeting of the American Epilepsy Society.
    • 08 May 2008 Status changed from recruiting to completed, as reported by Icagen.
    • 13 Sep 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top